These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 33369168)

  • 21. Arginine, an indispensable amino acid for patients with inborn errors of urea synthesis.
    Brusilow SW
    J Clin Invest; 1984 Dec; 74(6):2144-8. PubMed ID: 6511918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cross-sectional multicenter study of patients with urea cycle disorders in the United States.
    Tuchman M; Lee B; Lichter-Konecki U; Summar ML; Yudkoff M; Cederbaum SD; Kerr DS; Diaz GA; Seashore MR; Lee HS; McCarter RJ; Krischer JP; Batshaw ML;
    Mol Genet Metab; 2008 Aug; 94(4):397-402. PubMed ID: 18562231
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contrasting features of urea cycle disorders in human patients and knockout mouse models.
    Deignan JL; Cederbaum SD; Grody WW
    Mol Genet Metab; 2008 Jan; 93(1):7-14. PubMed ID: 17933574
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urea cycle disorders in Thai infants: a report of 5 cases.
    Wasant P; Srisomsap C; Liammongkolkul S; Svasti J
    J Med Assoc Thai; 2002 Aug; 85 Suppl 2():S720-31. PubMed ID: 12403252
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitation of phenylbutyrate metabolites by UPLC-MS/MS demonstrates inverse correlation of phenylacetate:phenylacetylglutamine ratio with plasma glutamine levels.
    Jiang Y; Almannai M; Sutton VR; Sun Q; Elsea SH
    Mol Genet Metab; 2017 Nov; 122(3):39-45. PubMed ID: 28888854
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo monitoring of urea cycle activity with (13)C-acetate as a tracer of ureagenesis.
    Opladen T; Lindner M; Das AM; Marquardt T; Khan A; Emre SH; Burton BK; Barshop BA; Böhm T; Meyburg J; Zangerl K; Mayorandan S; Burgard P; Dürr UH; Rosenkranz B; Rennecke J; Derbinski J; Yudkoff M; Hoffmann GF
    Mol Genet Metab; 2016 Jan; 117(1):19-26. PubMed ID: 26597322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glutaminase 2 knockdown reduces hyperammonemia and associated lethality of urea cycle disorder mouse model.
    Mao X; Chen H; Lin AZ; Kim S; Burczynski ME; Na E; Halasz G; Sleeman MW; Murphy AJ; Okamoto H; Cheng X
    J Inherit Metab Dis; 2022 May; 45(3):470-480. PubMed ID: 34988999
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced ornithine transcarbamylase activity does not impair ureagenesis in Otc(spf-ash) mice.
    Marini JC; Lee B; Garlick PJ
    J Nutr; 2006 Apr; 136(4):1017-20. PubMed ID: 16549467
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Variants associated with urea cycle disorders in Japanese patients: Nationwide study and literature review.
    Kido J; Matsumoto S; Sugawara K; Sawada T; Nakamura K
    Am J Med Genet A; 2021 Jul; 185(7):2026-2036. PubMed ID: 33851512
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnosis and treatment of urea cycle disorder in Japan.
    Nakamura K; Kido J; Mitsubuchi H; Endo F
    Pediatr Int; 2014 Aug; 56(4):506-9. PubMed ID: 25039902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Argininosuccinate neurotoxicity and prevention by creatine in argininosuccinate lyase deficiency: An in vitro study in rat three-dimensional organotypic brain cell cultures.
    Diez-Fernandez C; Hertig D; Loup M; Diserens G; Henry H; Vermathen P; Nuoffer JM; Häberle J; Braissant O
    J Inherit Metab Dis; 2019 Nov; 42(6):1077-1087. PubMed ID: 30907007
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correction of ornithine transcarbamylase deficiency in adult spf(ash) mice and in OTC-deficient human hepatocytes with recombinant adenoviruses bearing the CAG promoter.
    Kiwaki K; Kanegae Y; Saito I; Komaki S; Nakamura K; Miyazaki JI; Endo F; Matsuda I
    Hum Gene Ther; 1996 May; 7(7):821-30. PubMed ID: 8860834
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of rare variants causing urea cycle disorders: A clinical, genetic, and biophysical study.
    Liu F; Bao LS; Liang RJ; Zhao XY; Li Z; Du ZF; Lv SG
    J Cell Mol Med; 2021 Apr; 25(8):4099-4109. PubMed ID: 33611823
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dietary management of urea cycle disorders: European practice.
    Adam S; Almeida MF; Assoun M; Baruteau J; Bernabei SM; Bigot S; Champion H; Daly A; Dassy M; Dawson S; Dixon M; Dokoupil K; Dubois S; Dunlop C; Evans S; Eyskens F; Faria A; Favre E; Ferguson C; Goncalves C; Gribben J; Heddrich-Ellerbrok M; Jankowski C; Janssen-Regelink R; Jouault C; Laguerre C; Le Verge S; Link R; Lowry S; Luyten K; Macdonald A; Maritz C; McDowell S; Meyer U; Micciche A; Robert M; Robertson LV; Rocha JC; Rohde C; Saruggia I; Sjoqvist E; Stafford J; Terry A; Thom R; Vande Kerckhove K; van Rijn M; van Teeffelen-Heithoff A; Wegberg Av; van Wyk K; Vasconcelos C; Vestergaard H; Webster D; White FJ; Wildgoose J; Zweers H
    Mol Genet Metab; 2013 Dec; 110(4):439-45. PubMed ID: 24113687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decreased plasma l-arginine levels in organic acidurias (MMA and PA) and decreased plasma branched-chain amino acid levels in urea cycle disorders as a potential cause of growth retardation: Options for treatment.
    Molema F; Gleich F; Burgard P; van der Ploeg AT; Summar ML; Chapman KA; Lund AM; Rizopoulos D; Kölker S; Williams M;
    Mol Genet Metab; 2019 Apr; 126(4):397-405. PubMed ID: 30827756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prospective treatment of urea cycle disorders.
    Maestri NE; Hauser ER; Bartholomew D; Brusilow SW
    J Pediatr; 1991 Dec; 119(6):923-8. PubMed ID: 1720458
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improving long term outcomes in urea cycle disorders-report from the Urea Cycle Disorders Consortium.
    Waisbren SE; Gropman AL; ; Batshaw ML
    J Inherit Metab Dis; 2016 Jul; 39(4):573-84. PubMed ID: 27215558
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting autophagy for therapy of hyperammonemia.
    Soria LR; Brunetti-Pierri N
    Autophagy; 2018; 14(7):1273-1275. PubMed ID: 30035657
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of orotic acid measurement in routine newborn screening for urea cycle disorders.
    Staretz-Chacham O; Daas S; Ulanovsky I; Blau A; Rostami N; Saraf-Levy T; Abu Salah N; Anikster Y; Banne E; Dar D; Dumin E; Fattal-Valevski A; Falik-Zaccai T; Hershkovitz E; Josefsberg S; Khammash H; Keidar R; Korman SH; Landau Y; Lerman-Sagie T; Mandel D; Mandel H; Marom R; Morag I; Nadir E; Yosha-Orpaz N; Pode-Shakked B; Pras E; Reznik-Wolf H; Saada A; Segel R; Shaag A; Shaul Lotan N; Spiegel R; Tal G; Vaisid T; Zeharia A; Almashanu S
    J Inherit Metab Dis; 2021 May; 44(3):606-617. PubMed ID: 33190319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ammonia toxicity and its prevention in inherited defects of the urea cycle.
    Walker V
    Diabetes Obes Metab; 2009 Sep; 11(9):823-35. PubMed ID: 19531057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.